ASCGT
Early Data at ASGCT Support GPC3-Targeted CAR T-Cell Therapy Approach in Liver Cancer
Researchers treated patients with CAR T cells co-expressing IL-15, which increased anti-tumor activity but also toxicity, which was somewhat mitigated by a safety switch.